Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

3 results found

An MSF nurse performs a Cryptococcal Antigen (CrAg) screening test to test for Cryptococcal Meningitis in an AIDS patient.

Letter |

24 July 2018

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Tags HIV/AIDS cryptococcal meningitis antiretroviral medicines opportunistic infectionsWHO pre-qualification World Health Organization

Statement |

15 July 2014

MSF calls on BRICS countries to prioritize health and access to medical innovation

Tags Tuberculosis hepatitis CHIV/AIDStuberculosis 3Pinnovationresearch and development (R&D)

Angelina* is one of the 11% of people in Mozambique who are living with HIV; she also suffers from Kaposi’s Sarcoma, a type of cancer related to her condition, that causes painful and disfiguring lesions on the skin. Angelina sometimes develops wounds on her skin caused by infections secondary to HIV. “It’s happened that I scratch them until I can see the new skin below,” she says. “The skin goes up into the air like dust.” *Name has been changed

Opinion article |

18 July 2013

Treating Kaposi’s Sarcoma in Maputo, Mozambique

Tags HIV/AIDS HIV/AIDSΚaposi's sarcoma opportunistic infections Mozambique